NewslettersHuman Immunology NewsIL-11/IL-11R Signal Inhibition by 9MW3811 Remodels Immune Tumor Microenvironment and Enhances Anti-Tumor Efficacy of PD-1 BlockadeBy Jamie Kang - May 13, 20250105Scientists introduced 9MW3811, a monoclonal antibody designed to neutralize IL-11 effectively.[NPJ Precision Oncology]Full Article